Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Should Oversee Clinical Trial Disclosure, New York AG Spitzer Says

Executive Summary

FDA should take the lead in defining rules for clinical trial reporting to eliminate the issue of "publication bias," New York Attorney General Eliot Spitzer said during a recent appearance at the Chautauqua Institution in New York

You may also be interested in...



FDA Credibility Crisis: 1990 Generic Drug Scandal May Be Blueprint For 2005

FDA is heading into 2005 facing the most difficult challenge to its credibility as a regulatory agency since the generic drug scandal at the end of the 1980s

FDA Credibility Crisis: 1990 Generic Drug Scandal May Be Blueprint For 2005

FDA is heading into 2005 facing the most difficult challenge to its credibility as a regulatory agency since the generic drug scandal at the end of the 1980s

Forest Settles With Spitzer; Trial Registry Will Focus On Phase III-IV

Forest Labs' settlement agreement with New York Attorney General Eliot Spitzer requires less disclosure of clinical data than an earlier settlement between Spitzer and GlaxoSmithKline

Related Content

Topics

UsernamePublicRestriction

Register

PS044504

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel